DATAMEDS AI, INC.

NASDAQ: MEDS (DataMeds AI, Inc.)

Last update: 4 days ago, 3:13AM

0.640

0.00 (-0.28%)

Previous Close 0.642
Volume 551,574
Price / Sales 0.240
52 Weeks Range
0.493 (-23%) — 33.15 (5077%)
Profit Margin 52.46%
Operating Margin (TTM) -153.67%
Diluted EPS (TTM) -24.38
Total Debt/Equity (MRQ) 1.48%
Current Ratio (MRQ) 4.75
Return on Assets (TTM) -71.92%
Return on Equity (TTM) -269.31%

AIStockmoo Score

-2.1
Low debt. Weak profitability. Ample short-term liquidity. info
From our AI Insight report's view of expected return against risk. info NA
Relative Valuation info NA
Implied Growth info NA
Valuation History info NA
Return on Capital info NA
Earnings Trend info NA
Holdings' Value info NA
Risk Premium info NA
Market Valuation info NA
Downtrend over the past year. Far below its 52-week high. info
In a downtrend: the price is below its moving averages, and they are falling. It has dropped well below them. Volume is heavier on down days. info
From our AI technical analysis of the chart. info NA
Candle Patterns info NA
No recent price targets, so based on how targets have been revised. info
Holdings' Sentiment info NA
News Mood info NA
Institutions net +0.66% of shares in their latest 13F filings: 10 holders increased, 4 decreased (quarter to 30 Sep 2026). info
Short interest +113.5% from 31 Aug to 30 Oct 2026, 1 days to cover (FINRA). info
Insider Activity info NA
Market environment cautious. info
Sector lagging the market.
The pillars agree, so the score is strengthened.
Below its medium-term trend line. info
Price is low against its 52-week average. Down over 5 years. info
Trend down on all three terms. Short-term momentum falling. info
Levels trending up. info
Final Score -2.09
Show all

Market Trend

Short Term Medium Term
Industry Pharmaceutical Retailers (US) Mixed Mixed
Pharmaceutical Retailers (Global) Mixed Mixed
Stock DataMeds AI, Inc. Mixed Mixed

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B Score
MEDS - - - - -2.1
WBA 10 B 4.34% - 1.44 -2.0
PETS 19 M - - 1.18 -3.9
RDGT 853 K - - 0.020 -2.2
SCNX - - - 0.080 -1.6
HITI 199 M - - 2.95 -1.7

Select this tab to load the latest available analysis.

Trxade Health Inc is a health service IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey, and patient engagement in the U.S. Its products and services include Integra Pharma Solutions, LLC, Community Specialty Pharmacy, LLC, Delivmeds.com, Bonum Health Hub and Application, and others. its business is classified into reportable segments which are Trxade, Inc, Superlatus, LLC, Integra Pharma, LLC, and Other, and the majority of the revenue comes from Trxade, Inc.

Sector Healthcare
Industry Pharmaceutical Retailers
Investment Style Small Value
% Held by Insiders 63.99%
% Held by Institutions 10.25%

Ownership

Name Date Shares Held
Onedigital Investment Advisors Llc 30 Sep 2026 21,369

No data within this time range.

No data within this time range.

Institutions

Institutional ownership: 1.62%

Positions Holders Shares
Increased 10 49,514
Decreased 4 23,584
New 7 34,444
Sold out 1 20,532

SEC 13F filings via Nasdaq, latest filings up to 30 Sep 2026. Filings arrive up to 45 days after each quarter.

Short Interest

Settlement Shares Days to cover
30 Oct 2026 371,417 1.0
15 Oct 2026 476,294 1.0
30 Sep 2026 525,081 1.0
15 Sep 2026 430,628 1.0
31 Aug 2026 173,986 1.0
14 Aug 2026 164,850 1.0

FINRA short interest via Nasdaq, reported twice a month.

2 Positive 0 Negative 0 Neutral
Date Type Details
05 Nov 2026 Yahoo Finance DataMeds AI Signs Preliminary Agreement With Florida Health Insurer for GLP-1 Patient Management App
DataMeds AI, Inc. (NASDAQ:MEDS) announced that it has entered into a non-binding memorandum of understanding (MOU) with a Florida-based health maintenance organization (HMO) to introduce its Health Lives Here mobile application to the insurer’s members, initially focusing on patients receiving…
02 Nov 2026 Yahoo Finance DataMEDS AI Secures Supply Agreement for Six Compounded Peptides Following FDA Advisory Committee Recommendations
DataMEDS AI, Inc. (NASDAQ:MEDS) has announced that its pharmacy subsidiary, Corexa Health, has entered into a commercial supply agreement covering bulk drug substances and active pharmaceutical ingredients (APIs) for six peptides, as the company prepares to expand its compounded prescription…
23 Oct 2026 Yahoo Finance DataMEDS AI Establishes "Health Lives Here" Community Respiratory Program for Corexa Health Pharmacy Network
The aim of HLH CRP is to bring respiratory season best practices to community pharmacies and improve access to protein-based vaccines, diagnostics and therapeutics targeting respiratory infectious diseases as cold and flu season begins across the U. Corexa Pharmacy in Lakeland, Florida will be the…
20 Oct 2026 Yahoo Finance DataMeds Regains Compliance With NASDAQ Listing Standards
TAMPA, FL / ACCESS Newswire / October 20, 2026 / DataMeds AI, Inc. In order to regain compliance with the Equity Rule, DataMEDS needed to have a minimum stockholders' equity of $2…
16 Oct 2026 Yahoo Finance DataMeds AI Plans Peptide Compounding Expansion Through Corexa Health Following FDA Policy Proposal
DataMeds AI, Inc. (NASDAQ:MEDS) has outlined plans to expand into the peptide compounding market through its pharmacy subsidiary, Corexa Health, following a proposed policy change by the U.
16 Oct 2026 Yahoo Finance DataMeds Applauds FDA's Proposed Interim Access Policy for Compounding Using Certain Peptides and Provides Corexa Health's Peptides Roadmap
Corexa Health's three divisions - pharmacy, distribution, and tech & hub - positioned to serve the emerging compounded peptide marketTAMPA, FL / ACCESS Newswire / October 16, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS SI," "DataMEDS," or the "Company"), a healthcare company…
14 Oct 2026 Yahoo Finance DataMEDS Si Licenses U.S. Rights To Reboot Health AI's Direct-To-Consumer GLP-1 Weight Management Platform
Platform to be integrated into Health Lives Here app as a subscription offeringTAMPA, FL / ACCESS Newswire / October 14, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS SI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure…
13 Oct 2026 Yahoo Finance DataMEDS SI Provides Business Update On CLIA Lab Helomics And Its Super Intelligence Predictive Oncology Division
Leading Health IT Company has Implemented Cost Control Measures and Refocused Remaining Workforce Towards ChemoFx Commercialization with Hospital Systems, HMOs, GPOs and Cancer Centers TAMPA, FL – DataMeds AI, Inc. (NASDAQ:MEDS) (“DataMeds AI,” “DataMEDS SI,” “DataMEDS,” or the “Company”), a…
13 Oct 2026 Yahoo Finance DataMeds AI Announces Workforce Reductions as It Prioritises ChemoFx Cancer Diagnostic Test Commercialisation
DataMeds AI, Inc. (NASDAQ:MEDS) has announced cost-reduction measures, including cuts to corporate management positions, as the company redirects resources towards commercialising its ChemoFx diagnostic laboratory test for gynaecological cancers.
12 Oct 2026 Yahoo Finance DataMeds AI Secures Medicaid Coverage for ChemoFx Assay in Gynecologic Cancers
DataMeds AI’s Helomics subsidiary has received a Medicaid coverage determination under Humana’s policy, potentially expanding reimbursement access for its precision oncology test while supporting commercial growth. Key Investor TakeawaysDataMeds AI (NASDAQ:MEDS) has secured a Medicaid coverage…
12 Oct 2026 Yahoo Finance DataMEDS SI Announces Helomics Receives Medicaid Coverage Policy For Chemofx(R) Assay In Gynecologic Cancers
Humana adds ChemoFx® to its Medicaid Pharmacogenomics Testing coverage policyTAMPA, FL / ACCESS Newswire / October 12, 2026 / DataMeds AI, Inc. Medical Coverage Policies were reviewed by Humana's Medicaid Coverage Policy Adoption (MCPA) Forum, which incorporated the ChemoFx Assay in its Coverage…
01 Oct 2026 Yahoo Finance DataMeds AI Corexa Pharmacy Surpasses $1 Million in Monthly Revenue as Sales Rise 66%
Corexa Pharmacy’s preliminary September revenue increased more than 66% from July, supported by retail customer growth and the launch of Tollo Health products. Key Investor TakeawaysDataMeds AI (NASDAQ:MEDS) said Corexa Pharmacy generated preliminary, unaudited September 2026 revenue of more than…
01 Oct 2026 Yahoo Finance DataMeds AI's Corexa Pharmacy Surpasses $1 Million In Monthly Revenue
September 2026 revenue up more than 66 percent from July 2026 with expansion of retail customer base and Tollo Health pharmaceutical-adjunct product launchesTAMPA, FL / ACCESS Newswire / October 1, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a healthcare…
28 Sep 2026 Yahoo Finance Axe Compute Just Sold Its Cancer Business to Become an AI Stock
Axe Compute stock has rallied over 650% in the past six months as investors increasingly value it as an AI infrastructure stock. The challenge is now delivering on that promise.
28 Sep 2026 Yahoo Finance DataMeds AI Launches Health Lives Here App Focused on GLP-1 Telehealth and Pharmacy Services
DataMeds AI (NASDAQ:MEDS) and Tollo Health launched the Health Lives Here mobile application, combining GLP-1 telehealth, pharmacy services, nutritional products and health tracking as part of a planned broader healthcare network. Key Investor TakeawaysDataMeds AI (NASDAQ:MEDS) and Tollo Health…
28 Sep 2026 Yahoo Finance DataMeds AI stock rises on health app launch
Investing.com -- DataMeds AI Inc (NASDAQ:MEDS) shares jumped 25% Monday following the launch of its Health Lives Here mobile application in partnership with Tollo Health.
28 Sep 2026 Yahoo Finance DataMeds AI and Tollo Health Announce Launch of 'Health Lives Here' Mobile Application
Healthcare IT Company and Nutritional Products Maker to Work with NFL Alumni Health to Drive Awareness of GLP-1 Telehealth and Pharmacy ServicesTAMPA, FL / ACCESS Newswire / September 28, 2026 / DataMeds AI, Inc. The companies intend to expand the target patient populations in the fourth quarter of…
25 Sep 2026 Yahoo Finance DataMEDS AI To Present At 2026 National Telehealth and Virtual Care Summit
Interim Co-CEO to Discuss Growing Patient Desire to Own Health DataTAMPA, FL / ACCESS Newswire / September 25, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure together with its artificial…
Show more
Ex Date Announcement Date Payment Date Details
19 Jul 2024 08 Jul 2024 24 Jul 2024 1.5 Cash
25 Mar 2024 28 Feb 2024 22 Mar 2024 8 Cash

Technical Setup Medium

Trend order
Slope
Entry
Volume
In a downtrend: the price is below its moving averages, and they are falling. It has dropped well below them. Volume is heavier on down days.
Nearest resistance: 0.740 – 0.933 · strong level

AI Technical Analysis

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

Risk / Reward
TP1:
TP2:

Loss to SL against profit to each target, from EP. A ratio of 2 or more is usually sought.

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria